Active Cancer Biomarkers Grants

PI Namesort descending Organization - Company Title Major Program / Research Group FOA
Heinrich, Michael C Oregon Health & Science University Novel models for functional profiling of germline SDH variants associated with cancer PAR-20-292: NCI Clinical and Translational Exploratory/Developmental Studies
Herman, James G. University Of Pittsburgh At Pittsburgh Ultrasensitive Detection of Tumor Specific DNA Methylation Changes for the Early Detection of Lung Cancer Early Detection Research Network RFA-CA-16-009: The Early Detection Research Network: Biomarker Developmental Laboratories
Hirsch, Fred R Icahn School Of Medicine At Mount Sinai Vulnerability of SARS- CoV-2 Infection in Lung Cancer Based on Serological Antibody Analyses COVID Serology RFA-CA-20-038: Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence
Hitchins, Megan P Cedars-Sinai Medical Center Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age PA-20-185: NIH Research Project Grant
Hollingsworth, Michael A. University Of Nebraska Medical Center Pancreatic Cancer Detection Consortium Pancreatic Cancer Detection Consortium PAR-21-334: Pancreatic Cancer Detection Consortium: Research Units
Houghton, A Mcgarry Fred Hutchinson Cancer Center Tumor-specific autoantibodies for SCLC early detection PA-19-056: Research Project Grant
Hur, Chin Columbia University Health Sciences Optimal Colorectal Cancer Surveillance Strategy for Lynch Syndrome by Genotype PA-20-185: NIH Research Project Grant
Iagaru, Andrei Stanford University Molecular Imaging Methods for the Detection of Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Detection Consortium PAR-15-289: The Pancreatic Cancer Detection Consortium
Ibsen, Stuart D. Oregon Health & Science University Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Ibsen, Stuart D. Oregon Health & Science University Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers PAR-20-053: Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection
Ivanov, Alexander R. Northeastern University Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection PA-20-272: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Iyer, Prasad G. Mayo Clinic Rochester Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma PAR-18-559: Cancer Prevention and Control Clinical Trials Grant Program
Jiang, Feng University Of Maryland Baltimore Plasma biomarkers for lung cancer diagnosis PAR-18-317: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)
Kalluri, Raghu University Of Tx Md Anderson Can Ctr Rigorous and reproducible mutational analysis of the urinary exosomal DNA PAR-16-276: Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection
Kanwal, Fasiha Baylor College Of Medicine Risk Stratification for and Early Detection of Liver Cancer Translational Liver Consortium RFA-CA-17-025: Consortium on Translational Research in Early Detection of Liver Cancer (Clinical and Research Centers (U01)

Pages